A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Share this content:

A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Sponsors and Collaborators
Kissei Pharmaceutical Co., Ltd.

Contact
Kissei Pharmaceutical Co., Ltd
rinsyousiken@pharm.kissei.co.jp

ClinicalTrials.gov Identifier
NCT01833494

Loading links....

Sign Up for Free e-newsletters